Clinical trial
A Study of GT160-246 Versus Vancomycin in Patients With Clostridium…
NCT00034294 · Genzyme, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00034294 |
|---|---|
| Title | A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea |
| Official title | A Randomized, Double-Blind Study of GT160-246 Versus Vancomycin in Patients With C. Difficile-Associated Diarrhea |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Clostridium Difficile-Associated Diarrhea, Clostridium Enterocolitis, Clostridium Difficile Diarrhea, Antibiotic-associated Colitis, Antibiotic-associated Diarrhea |
| Intervention type | Drug |
| Interventions | GT160-246 |
| Enrollment | 300 |
| Start date | Feb 1, 2002 |
| Completion | Jul 1, 2003 |
| First posted | Apr 25, 2002 |
| Last update posted | Mar 5, 2015 |
| Countries | Canada, Puerto Rico, United Kingdom, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: